Neoadjuvant chemotherapy using gemcitabine and S-1 significantly outperforms upfront surgery for patients with resectable pancreatic ductal adenocarcinoma (PDAC). In a randomized trial with 364 participants, median overall survival was 37.0 months for the chemotherapy group compared to 26.6 months for the surgery group, with a hazard ratio of 0.73. Additionally, median relapse-free survival was extended […]
Category: HPB & Spleen
Idarubicin surpasses gemcitabine and cisplatin in effectiveness.
In a study investigating treatment options for unresectable intrahepatic cholangiocarcinoma (ICCA), idarubicin exhibited the highest cytotoxicity among ten tested drugs, greatly outperforming the standard gemcitabine and cisplatin combination. Tumor growth was significantly inhibited in mouse models treated with idarubicin and gemcis, with pronounced effects particularly noted on days 12 and 15. Preliminary clinical findings also […]
New method predicts survival in borderline pancreatic cancer
Carbohydrate antigen 19-9 (CA19-9) evaluation through a novel method significantly predicts overall and disease-free survival in borderline resectable pancreatic adenocarcinoma patients undergoing neoadjuvant therapy. A study with 991 participants revealed that those with a mean Δf below defined thresholds demonstrated significantly improved prognoses, associating with hazard ratios for overall survival of 0.6 and 0.4 for […]
Multimodal AI model significantly enhances HCC detection accuracy
A multimodal artificial intelligence model demonstrated impressive results for hepatocellular carcinoma (HCC) detection. Evaluations from 1,092 participants across training, internal validation, and external validation cohorts showed the model’s area under the curve (AUC) values reaching 0.985 and 0.915. Notably, it excelled in identifying small HCCs and those negative for alpha-fetoprotein, achieving AUCs of 0.996 and […]
Novel model enhances prognosis prediction in intrahepatic cholangiocarcinoma
A multidisciplinary framework successfully identified 85 genes linked to panoptosis in intrahepatic cholangiocarcinoma (ICC) patients. Researchers developed a panoptosis risk score (panrs) model with five critical hub genes, demonstrating high efficacy in prognosis prediction across diverse cohorts. The study also highlighted macrophage roles in the tumor microenvironment and established a link between postn overexpression and […]
HAIC enhances treatment outcomes for advanced hepatocellular carcinoma
A meta-analysis involving 1,244 patients found that hepatic arterial infusion chemotherapy (HAIC) combined with lenvatinib and PD-1 inhibitors significantly improved overall survival (OS) and progression-free survival (PFS) compared to lenvatinib with PD-1 inhibitors alone. Specifically, this combination led to a hazard ratio of 2.11 for OS and 1.91 for PFS. Additionally, the objective response rate […]
Standardized nursing process enhances recovery in cholelithiasis patients
Standardizing nursing processes for abdominal drainage in cholelithiasis patients significantly improves recovery outcomes. A retrospective study involving 264 patients revealed that those treated with standardized protocols reported substantially less postoperative pain, greater activity levels within 24 hours, and reduced leakage incidents compared to those who received non-standardized care. Additionally, patient satisfaction was notably higher in […]
Advanced EUS imaging enhances diagnosis and treatment success rates
Endoscopic ultrasonography (EUS) with novel scopes and ultrasound systems proves effective for diagnosing pancreaticobiliary diseases, evidenced by a 100% success rate in interventional procedures. Although shear wave velocity (SWV) showed no significant differences among various pancreatic conditions, variations in effective SWV were noted. The advanced imaging techniques, including detective flow imaging (DFI) and shear wave […]
Robotic-assisted hepatectomy proves cost-effective and safe.
Findings indicate that robotic-assisted hepatectomy in a high-volume center leads to shorter hospital stays, fewer complications, and lower severe morbidity rates compared to traditional methods. Analyzing 111 patients from Lille University Hospital revealed costs dropped from €12,169 in 2018 to €8,513 in 2021, cumulatively saving €259,576 for the 71 patients in the latter cohort. These […]
Rising burden of gallbladder diseases amid improved age-standardized rates
The global health burden of gallbladder and biliary diseases persists, with the age-standardized incidence rate decreasing by 12.84% from 1990 to 2021. However, the absolute number of cases increased by 60.11%, primarily due to population aging and growth. Health inequalities persist, particularly in high-burden regions like Honduras, with disparities in healthcare workforce density relative to […]